Oranges may hold the key to reducing obesity and diabetes

Credit: Pixabay/ Pexels

A recent study from Western University found a molecule in sweet oranges and tangerines called nobiletin may help reduce obesity and prevent diabetes and heart disease.

The team found that mice fed a high-fat, high-cholesterol diet that was also given nobiletin were noticeably leaner and had reduced levels of insulin resistance and blood fats compared to mice that were fed a high-fat, high-cholesterol diet alone.

They also found that in mice that already had all the negative symptoms of obesity, they could use nobelitin to reverse those symptoms, and even start to regress plaque build-up in the arteries, known as atherosclerosis.

The researchers hypothesized that the molecule was likely acting on the pathway that regulates how fat is handled in the body.

Called AMP Kinase, this regulator turns on the machinery in the body that burns fats to create energy, and it also blocks the manufacture of fats.

But this result told us that nobiletin is not acting on AMP Kinase, and is bypassing this major regulator of how fat is used in the body.

The team says while the mystery remains, this result is still clinically important because it shows that nobiletin won’t interfere with other drugs that act on the AMP Kinase system.

The next step is to move these studies into humans to determine if nobiletin has the same positive metabolic effects in human trials.

If you care about diabetes and obesity, please read studies about doing this frequently may help reduce type 2 diabetes and the findings of these common drugs linked to higher risk of type 2 diabetes.

For more information about diabetes and obesity, please see recent studies about an egg a day linked to a 60% higher diabetes risk and results showing that this treatment for type 2 diabetes remains effective after 2 years.

The study was published in the Journal of Lipid Research and conducted by Murray Huff et al.

Copyright © 2022 Knowridge Science Report. All rights reserved.